Eastwood Bio-Medical Canada Inc. (TSXV: EBM)
Health Care · Health Care Providers & Services · CA
CA$1.70
-5.56% today · +457.4% 1Y
Eastwood Bio-Medical Canada Inc. (TSXV: EBM) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $85.05M and employs 3 people.
Over the last twelve months the share price has gained 457.4%, trading between 0.30 and 1.97.
Tweenvest scores Eastwood Bio-Medical Canada Inc. across four factors: quality 34/100, value 42/100, growth 53/100. Its strongest factor is growth.
EBM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $85.05M
- Revenue (TTM)
- $578.73K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.11
- 52-week high
- CA$1.97
- 52-week low
- CA$0.30
- Avg volume (3M)
- —
- Shares outstanding
- 68.89M
- Employees
- 3
- Next earnings
- —
About Eastwood Bio-Medical Canada Inc.
Eastwood Bio-Medical Canada Inc., established in Richmond, Canada, in 2010, is a company focused on the worldwide marketing and distribution of natural health products. Operating under the Eleotin brand, their offerings are available across Canada, the United States, and Asian regions. The firm's core mission is to deliver natural remedies for prevalent metabolic disorders, including issues with blood glucose regulation, hypertension, and obesity. Their extensive portfolio of licensed Eleotin products addresses diverse health requirements. For individuals experiencing spleen deficiency, appetite loss, or fatigue, Eleotin A 700 provides support. Eleotin AL88 serves as a laxative, while Eleotin Cal20 aids in the maintenance of healthy bones and teeth. Eleotin V3D is formulated for the development and upkeep of strong bones, teeth, and overall well-being. To support cardiovascular health, they offer Eleotin G2000. Eleotin H55 is designed to act as a sedative and alleviate tension, and Eleotin Zn330 is vital for tissue formation and metabolic processes. Furthermore, their product line includes Eleotin Bentley, which promotes balanced glucose levels, and Eleotin LBM, intended for hypertension relief.
- ISIN
- CA27783W1059
- Founded
- 2010
- Listed since
- Aug 23, 2018
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $359.94B | $401.01 | +1.11% |
| CVS Health CorporationNYSE: CVS | $120.63B | $94.32 | +1.53% |
| McKesson CorporationNYSE: MCK | $104.54B | $896.65 | -0.93% |
| HCA Healthcare, Inc.NYSE: HCA | $92.48B | $427.16 | -0.37% |
| Elevance Health, Inc.NYSE: ELV | $87.30B | $402.54 | +0.92% |
| The Cigna GroupNYSE: CI | $74.22B | $280.87 | +0.55% |
| Cencora, Inc.NYSE: COR | $62.55B | $327.79 | -0.08% |
| Cardinal Health, Inc.NYSE: CAH | $55.45B | $238.40 | +0.20% |
Figures last refreshed Aug 18, 2026.